Real-time enrollment status for this osteogenesis imperfecta clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 12:19 AM UTC
| NCT Number | NCT07366086 |
| Recruiting Status | Recruiting |
| Condition | Osteogenesis Imperfecta |
| Phase | PHASE3 |
| Target Enrollment | 71 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Amgen |
| Last Updated on CT.gov | June 22, 2026 (Jun 22, 2026) |
As of August 28, 2026: Clinical trial NCT07366086 is currently recruiting participants. This phase3 study for osteogenesis imperfecta is actively seeking new participants at 1 location across the United States. The study is sponsored by Amgen. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07366086 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07366086 was last updated Jun 22, 2026 (June 22, 2026). HelloStudys verifies this status automatically.